Test Your HIV Management Skills Across the Spectrum of Care: From Newly Diagnosed to Aging Patients With HIV

Faculty

Seble G. Kassaye, MD, MS
Associate Professor of Medicine
Department of Medicine
Division of Infectious Diseases
Georgetown University
Washington, District of Columbia

Sarah E. Rowan, MD
Associate Professor of Medicine
Divisions of Infectious Diseases and Internal Medicine
Associate Director, Mentored Scholarly Activity
University of Colorado School of Medicine
Associate Director of HIV and Viral Hepatitis Prevention
Denver Health
Denver, Colorado

Target Audience

This activity is intended for infectious disease and HIV specialists related to HIV clinical management skills, with the overall goal of the program to improve the care of patients with HIV.

Educational Objectives

Upon completion of this program, the participant should be better able to:

• Employ appropriate switching strategies in aging patients with multiple comorbidities by considering drug-drug interactions, patient characteristics, patient preference, and risk factors for worsening comorbidities
• Tailor ART regimens for transgender patients with HIV to avoid interactions with gender-affirming hormone therapy, account for patient preference, and improve adherence
• Initiate treatment with ART for all eligible patients as soon as possible following diagnosis of HIV 

Program Description

HIV is a rapidly evolving field and treatment decisions must be carefully tailored to each patient to improve their outcomes and their adherence. To best treat their patients, clinicians must be familiar with the nuances of ART selection, drug-drug interactions, switching strategies, and how best to care for the whole patient. This activity will examine an older patient with common comorbidities, such as cardiovascular disease and depression, a transgender woman who is concerned about interactions between her antiretroviral therapy and gender affirming hormones and is unstably housed, and a newly diagnosed man who uses drugs recreationally. This activity of 3 simulated patient cases will allow learners to hear patient/clinician interactions, make treatment decisions for the patient, learn what optimal decisions should be, and review data supporting those choices. 

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Integritas Communications. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.25 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must review the activity as well as successfully complete the posttest and evaluation form.

System Requirements

PC
1.4 GHz Intel Pentium 4 or faster processor (or equivalent)
Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)
512 MB of RAM (1 GB recommended)
Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome
For HTML Client – Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above)

MAC 
1.83 GHz Intel Core Duo or faster processor
512 MB of RAM (1 GB recommended)
MAC OS X 10.12, 10.13 and 10.14
Mozilla Firefox, Apple Safari, Google Chrome
For HTML Client – Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above) 

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Seble G. Kassaye, MD, MS has nothing to disclose

Sarah E. Rowan, MD has nothing to disclose

The PIM planners and managers have nothing to disclose. The Integritas Communications planners and managers have nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. The planners of this activity do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.